Thus these results collectively indicate that knockdownof CD276 inhibits the DNA damage repair capacity of 786-O cells and 786-O/Rcells, thereby increasing the sensitivity of the ccRCC cell model tosunitinib. Here, CD276 is linked to nonpapillary renal cell carcinoma.